Abstract
MicroRNAs are small noncoding RNAs which regulate the expression of genes involved in a multitude of cellular processes. Dysregulation of microRNAs and—in consequence—of the affected pathways is frequently observed in numerous pathologies including cancers. Therefore, tumor-related alterations in microRNA expression and function can reflect molecular processes of tumor onset and progression qualifying microRNAs as potential diagnostic and prognostic biomarkers.
In particular, microRNAs with differential expression in bladder cancer (BCa) might represent promising tools for noninvasive tumor detection in urine. This would be helpful not only for diagnostic and monitoring purposes but also for therapeutic decisions. Detection and quantification of BCa-associated microRNAs in urine can be performed using the cellular sediment, which also contains BCa cells, or in exosomes originating from those cells. Methods for isolation of exosomes from urine, extraction of total RNA from cells and exosomes as well as techniques for RNA quantification, reverse transcription, and qPCR-based quantification of microRNA expression levels are described herein.
Similar content being viewed by others
References
Carrington JC, Ambros V (2003) Role of microRNAs in plant and animal development. Science 301(5631):336–338. doi:10.1126/science.1085242
Mlcochova H, Hezova R, Stanik M, Slaby O (2014) Urine microRNAs as potential noninvasive biomarkers in urologic cancers. Urol Oncol 32(1):41 e41–41 e49. doi:10.1016/j.urolonc.2013.04.011
Fendler A, Stephan C, Yousef GM, Jung K (2011) MicroRNAs as regulators of signal transduction in urological tumors. Clin Chem 57(7):954–968. doi:10.1373/clinchem.2010.157727
Schubert M, Junker K, Heinzelmann J (2016) Prognostic and predictive miRNA biomarkers in bladder, kidney and prostate cancer: where do we stand in biomarker development? J Cancer Res Clin Oncol 142(8):1673–1695. doi:10.1007/s00432-015-2089-9
Catto JW, Alcaraz A, Bjartell AS, De Vere WR, Evans CP, Fussel S, Hamdy FC, Kallioniemi O, Mengual L, Schlomm T, Visakorpi T (2011) MicroRNA in prostate, bladder, and kidney cancer: a systematic review. Eur Urol 59(5):671–681. doi:10.1016/j.eururo.2011.01.044
Ouyang H, Zhou Y, Zhang L, Shen G (2015) Diagnostic value of microRNAs for urologic cancers: a systematic review and meta-analysis. Medicine (Baltimore) 94(37):e1272. doi:10.1097/md.0000000000001272
Canturk KM, Ozdemir M, Can C, Oner S, Emre R, Aslan H, Cilingir O, Ciftci E, Celayir FM, Aldemir O, Ozen M, Artan S (2014) Investigation of key miRNAs and target genes in bladder cancer using miRNA profiling and bioinformatic tools. Mol Biol Rep 41(12):8127–8135. doi:10.1007/s11033-014-3713-5
Dyrskjot L, Ostenfeld MS, Bramsen JB, Silahtaroglu AN, Lamy P, Ramanathan R, Fristrup N, Jensen JL, Andersen CL, Zieger K, Kauppinen S, Ulhoi BP, Kjems J, Borre M, Orntoft TF (2009) Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. Cancer Res 69(11):4851–4860. doi:10.1158/0008-5472.can-08-4043
Han Y, Chen J, Zhao X, Liang C, Wang Y, Sun L, Jiang Z, Zhang Z, Yang R, Li Z, Tang A, Li X, Ye J, Guan Z, Gui Y, Cai Z (2011) MicroRNA expression signatures of bladder cancer revealed by deep sequencing. PLoS One 6(3):e18286. doi:10.1371/journal.pone.0018286
Ichimi T, Enokida H, Okuno Y, Kunimoto R, Chiyomaru T, Kawamoto K, Kawahara K, Toki K, Kawakami K, Nishiyama K, Tsujimoto G, Nakagawa M, Seki N (2009) Identification of novel microRNA targets based on microRNA signatures in bladder cancer. Int J Cancer 125(2):345–352. doi:10.1002/ijc.24390
Itesako T, Seki N, Yoshino H, Chiyomaru T, Yamasaki T, Hidaka H, Yonezawa T, Nohata N, Kinoshita T, Nakagawa M, Enokida H (2014) The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster. PLoS One 9(2):e84311. doi:10.1371/journal.pone.0084311
Zaravinos A, Radojicic J, Lambrou GI, Volanis D, Delakas D, Stathopoulos EN, Spandidos DA (2012) Expression of miRNAs involved in angiogenesis, tumor cell proliferation, tumor suppressor inhibition, epithelial-mesenchymal transition and activation of metastasis in bladder cancer. J Urol 188(2):615–623. doi:10.1016/j.juro.2012.03.122
Catto JW, Miah S, Owen HC, Bryant H, Myers K, Dudziec E, Larre S, Milo M, Rehman I, Rosario DJ, Di Martino E, Knowles MA, Meuth M, Harris AL, Hamdy FC (2009) Distinct microRNA alterations characterize high- and low-grade bladder cancer. Cancer Res 69(21):8472–8481. doi:10.1158/0008-5472.can-09-0744
Dip N, Reis ST, Timoszczuk LS, Viana NI, Piantino CB, Morais DR, Moura CM, Abe DK, Silva IA, Srougi M, Dall'Oglio MF, Leite KR (2012) Stage, grade and behavior of bladder urothelial carcinoma defined by the microRNA expression profile. J Urol 188(5):1951–1956. doi:10.1016/j.juro.2012.07.004
Pignot G, Cizeron-Clairac G, Vacher S, Susini A, Tozlu S, Vieillefond A, Zerbib M, Lidereau R, Debre B, Amsellem-Ouazana D, Bieche I (2013) microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer. Int J Cancer 132(11):2479–2491. doi:10.1002/ijc.27949
Sapre N, Macintyre G, Clarkson M, Naeem H, Cmero M, Kowalczyk A, Anderson PD, Costello AJ, Corcoran NM, Hovens CM (2016) A urinary microRNA signature can predict the presence of bladder urothelial carcinoma in patients undergoing surveillance. Br J Cancer 114(4):454–462. doi:10.1038/bjc.2015.472
Veerla S, Lindgren D, Kvist A, Frigyesi A, Staaf J, Persson H, Liedberg F, Chebil G, Gudjonsson S, Borg A, Mansson W, Rovira C, Hoglund M (2009) MiRNA expression in urothelial carcinomas: important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31. Int J Cancer 124(9):2236–2242. doi:10.1002/ijc.24183
Zhou H, Tang K, Xiao H, Zeng J, Guan W, Guo X, Xu H, Ye Z (2015) A panel of eight-miRNA signature as a potential biomarker for predicting survival in bladder cancer. J Exp Clin Cancer Res 34:53. doi:10.1186/s13046-015-0167-0
Huang X, Liang M, Dittmar R, Wang L (2013) Extracellular microRNAs in urologic malignancies: chances and challenges. Int J Mol Sci 14(7):14785–14799. doi:10.3390/ijms140714785
Armstrong DA, Green BB, Seigne JD, Schned AR, Marsit CJ (2015) MicroRNA molecular profiling from matched tumor and bio-fluids in bladder cancer. Mol Cancer 14:194. doi:10.1186/s12943-015-0466-2
Eissa S, Habib H, Ali E, Kotb Y (2015) Evaluation of urinary miRNA-96 as a potential biomarker for bladder cancer diagnosis. Med Oncol 32(1):413. doi:10.1007/s12032-014-0413-x
Eissa S, Matboli M, Essawy NO, Kotb YM (2015) Integrative functional genetic-epigenetic approach for selecting genes as urine biomarkers for bladder cancer diagnosis. Tumour Biol 36(12):9545–9552. doi:10.1007/s13277-015-3722-6
Eissa S, Matboli M, Hegazy MG, Kotb YM, Essawy NO (2015) Evaluation of urinary microRNA panel in bladder cancer diagnosis: relation to bilharziasis. Transl Res 165(6):731–739. doi:10.1016/j.trsl.2014.12.008
Hanke M, Hoefig K, Merz H, Feller AC, Kausch I, Jocham D, Warnecke JM, Sczakiel G (2010) A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer. Urol Oncol 28(6):655–661. doi:10.1016/j.urolonc.2009.01.027
Mengual L, Lozano JJ, Ingelmo-Torres M, Gazquez C, Ribal MJ, Alcaraz A (2013) Using microRNA profiling in urine samples to develop a non-invasive test for bladder cancer. Int J Cancer 133(11):2631–2641. doi:10.1002/ijc.28274
Sasaki H, Yoshiike M, Nozawa S, Usuba W, Katsuoka Y, Aida K, Kitajima K, Kudo H, Hoshikawa M, Yoshioka Y, Kosaka N, Ochiya T, Chikaraishi T (2016) Expression level of urinary microRNA-146a-5p is increased in patients with bladder bancer and decreased in those after transurethral resection. Clin Genitourin Cancer 14(5):e493–e499. doi:10.1016/j.clgc.2016.04.002
Snowdon J, Boag S, Feilotter H, Izard J, Siemens DR (2013) A pilot study of urinary microRNA as a biomarker for urothelial cancer. Can Urol Assoc J 7(1–2):28–32. doi:10.5489/cuaj.11115
Yamada Y, Enokida H, Kojima S, Kawakami K, Chiyomaru T, Tatarano S, Yoshino H, Kawahara K, Nishiyama K, Seki N, Nakagawa M (2011) MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology. Cancer Sci 102(3):522–529. doi:10.1111/j.1349-7006.2010.01816.x
Zhang DZ, Lau KM, Chan ES, Wang G, Szeto CC, Wong K, Choy RK, Ng CF (2014) Cell-free urinary microRNA-99a and microRNA-125b are diagnostic markers for the non-invasive screening of bladder cancer. PLoS One 9(7):e100793. doi:10.1371/journal.pone.0100793
Mengual L, Ribal MJ, Lozano JJ, Ingelmo-Torres M, Burset M, Fernandez PL, Alcaraz A (2014) Validation study of a noninvasive urine test for diagnosis and prognosis assessment of bladder cancer: evidence for improved models. J Urol 191(1):261–269. doi:10.1016/j.juro.2013.06.083
Puerta-Gil P, Garcia-Baquero R, Jia AY, Ocana S, Alvarez-Mugica M, Alvarez-Ossorio JL, Cordon-Cardo C, Cava F, Sanchez-Carbayo M (2012) miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer. Am J Pathol 180(5):1808–1815. doi:10.1016/j.ajpath.2012.01.034
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Fuessel, S., Lohse-Fischer, A., Vu Van, D., Salomo, K., Erdmann, K., Wirth, M.P. (2018). Quantification of MicroRNAs in Urine-Derived Specimens. In: Schulz, W., Hoffmann, M., Niegisch, G. (eds) Urothelial Carcinoma. Methods in Molecular Biology, vol 1655. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7234-0_16
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7234-0_16
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7233-3
Online ISBN: 978-1-4939-7234-0
eBook Packages: Springer Protocols